Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: J Rheumatol. 2019 Mar 1;46(7):685–693. doi: 10.3899/jrheum.180724

Table 4.

Associations of HLA-DRB1 haplotypes with subcutaneous nodules and radiographic changes.

Haplotype Subcutaneous nodules Odds ratio (95% CI) ACR Radiographic Changes Odds ratio (95% CI)
VKA 1.03 (0.81, 1.32) 1.39 (1.08, 1.80)
VRA 1.02 (0.79, 1.31) 0.97 (0.75, 1.26)
LRA 1.16 (0.90, 1.50) 0.96 (0.73, 1.25)
PRA 1.40 (0.72, 2.72) 1.15 (0.58, 2.30)
VRE 1.14 (0.62, 2.10) 1.81 (0.91, 3.64)
DRE 1.24 (0.70, 2.17) 1.67 (0.93, 2.98)
VEA 0.73 (0.19, 2.81) 2.11 (0.50, 8.82)
SKA 1.15 (0.62, 2.14) 1.10 (0.58, 2.10)
PAA 1.01 (0.76, 1.35) 1.29 (0.96, 1.72)
GRQ 0.85 (0.63, 1.16) 0.82 (0.61, 1.12)
SRA 1.02 (0.73, 1.41) 0.71 (0.51, 1.00)
SRE 0.68 (0.32, 1.44) 0.61 (0.30, 1.26)
LEA 0.91 (0.34, 2.44) 0.63 (0.23, 1.72)
SRL 1.22 (0.70, 2.12) 1.12 (0.63, 2.02)
SKR 0.90 (0.66, 1.22) 0.88 (0.64, 1.20)
SEA 0.84 (0.60, 1.16) 0.76 (0.55, 1.05)
Other genetic parameters
Valine at position 11 1.06 (0.84, 1.35) 1.31 (1.04, 1.67)
Shared epitope positive 1.25 (0.96, 1.63) 1.23 (0.95, 1.60)

Values OR (95% CI) adjusting for age, sex, race, smoking status, and disease duration.